Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study

Overview of attention for article published in BMC Cancer, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 16 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study. https://t.co/Gc3GNIqL1J #MMSM #MultipleMyeloma #hematology https://t.co/gDurZOkdY

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.